Search

Author/Creator Duggal, Abhijit

72. Double-blind randomized proof-of-concept trial of canakinumab in patients with COVID-19 associated cardiac injury and heightened inflammation. Issue 1 (29th July 2021)

Authors:
Cremer, Paul C; Sheng, Calvin C; Sahoo, Debasis; Dugar, Siddharth; Prada, Robier Aguillon; Wang, Tom Kai Ming; Hassan, Ossama K Abou; Hernandez-Montfort, Jamie; Wolinsky, David A; Culver, Daniel A; Rajendram, Prabalini; Duggal, Abhijit; Brennan, Danielle M; Wolski, Katherine E; Lincoff, A Michael...
Journal:
European Heart Journal Open
Issue:
Volume 1:Issue 1(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

75. Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021. (21st December 2021)

Authors:
Lewis, Nathaniel M; Naioti, Eric A; Self, Wesley H; Ginde, Adit A; Douin, David J; Keipp Talbot, H; Casey, Jonathan D; Mohr, Nicholas M; Zepeski, Anne; Gaglani, Manjusha; Ghamande, Shekhar A; McNeal, Tresa A; Shapiro, Nathan I; Gibbs, Kevin W; Clark Files, D; Hager, David N; Shehu, Arber; Pr...
Journal:
Journal of infectious diseases
Issue:
Volume 225:Number 10(2022)
Page Start:
1694
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

76. Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States. (6th August 2021)

Authors:
Tenforde, Mark W; Patel, Manish M; Ginde, Adit A; Douin, David J; Talbot, H Keipp; Casey, Jonathan D; Mohr, Nicholas M; Zepeski, Anne; Gaglani, Manjusha; McNeal, Tresa; Ghamande, Shekhar; Shapiro, Nathan I; Gibbs, Kevin W; Files, D Clark; Hager, David N; Shehu, Arber; Prekker, Matthew E; Erickson...
Journal:
Clinical infectious diseases
Issue:
Volume 74:Number 9(2022)
Page Start:
1515
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

77. Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States . (8th June 2022)

Authors:
Lewis, Nathaniel M; Self, Wesley H; Gaglani, Manjusha; Ginde, Adit A; Douin, David J; Keipp Talbot, H; Casey, Jonathan D; Mohr, Nicholas M; Zepeski, Anne; Ghamande, Shekhar A; McNeal, Tresa A; Shapiro, Nathan I; Gibbs, Kevin W; Files, D Clark; Hager, David N; Shehu, Arber; Prekker, Matthew E; Eri...
Journal:
Clinical infectious diseases
Issue:
Volume 75(2022)Supplement 2
Page Start:
S159
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

79. Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial. Issue 5 (May 2022)

Authors:
Self, Wesley H.; Sandkovsky, Uriel; Reilly, Cavan S.; Vock, David M.; Gottlieb, Robert L.; Mack, Michael; Golden, Kevin; Dishner, Emma; Vekstein, Andrew; Ko, Emily R.; Der, Tatyana; Franzone, John; Almasri, Eyad; Fayed, Mohamed; Filbin, Michael R.; Hibbert, Kathryn A.; Rice, Todd W.; Casey, Jonat...
Journal:
Lancet infectious diseases
Issue:
Volume 22:Issue 5(2022)
Page Start:
622
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗